Related Experiment Videos
Immobilized adriamycin: a tool for separating cell surface from intracellular mechanisms
Federation Proceedings
|February 1, 1983
Summary
Adriamycin, an anticancer drug, may target cell membranes instead of DNA. Researchers attached adriamycin to supports, demonstrating its cytotoxic effects without cell entry, suggesting a new mechanism of action.
Area of Science:
- Pharmacology
- Cell Biology
- Biochemistry
Background:
- Pharmacologic agents can act at the cell membrane.
- Adriamycin is an anticancer agent with a known DNA intercalation mechanism.
- Emerging evidence suggests the cell surface membrane as a potential alternative target for adriamycin.
Purpose of the Study:
- To investigate the hypothesis that adriamycin exerts biological activity at the cell surface membrane.
- To determine if adriamycin can be cytotoxic without entering cells.
Main Methods:
- Adriamycin was chemically conjugated to insoluble solid supports.
- Cytotoxicity assays were performed under conditions designed to prevent intracellular drug entry.
Main Results:
- Demonstrated that adriamycin, when immobilized on a support, exhibited significant cytotoxic activity.
- Confirmed that the observed cytotoxicity occurred independently of adriamycin entering the cells.
Conclusions:
- The cell surface membrane is a viable target for adriamycin's anticancer activity.
- Adriamycin can exert potent cytotoxic effects by interacting with the cell membrane, independent of nuclear DNA intercalation.